The intra-aortic balloon pump (IABP) is a mechanical device used to assist cardiac circulatory function in patients suffering from cardiogenic shock, congestive heart failure, refractory angina and complications of myocardial infarction. While using IABP in cardiac surgery is well established, there are few studies on the utility of IABP support in high-risk cardiac patients undergoing non-cardiac surgery. Major non-cardiac surgeries are associated with high rates of cardiac complications in patients with advanced coronary disease. Recent case studies have reported favorable outcomes with the use of IABP support in non-cardiac surgery in patients with severe cardiac compromise. Using IABP may reduce cardiac complications by providing hemodynamic stability. Here, we present five cases of IABP use in high-risk cardiac patients undergoing resection and anastomosis of the trachea. IABP was inserted prior to induction of anesthesia in four of the cases, while IABP insertion was withheld in one case. In the four cases where IABP support was utilized, the IABP was removed between 6-48 hours postoperatively with no complications. The patient who did not undergo IABP insertion died on the 8th postoperative day due to uncontrollable pulmonary edema and progressive myocardial infarction. We also review the literature and discuss the role of IABP use in non-cardiac surgery.
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INTRODUCTION
The intra-aortic balloon pump (IABP) is a widely used circulatory assist device inserted percutaneously via the femoral artery (alternatively, the subclavian, axillary or iliac arteries) into the descending thoracic aorta (1, 2) . The balloon inflates during diastole, leading to an increasing diastolic pressure, thereby enhancing coronary artery blood flow and augmenting myocardial perfusion.
The balloon deflates during systole, reducing after load, decreasing myocardial oxygen demand and increasing myocardial oxygen reserve (1) (2) (3) (4), and maxillofacial surgery (9) and in patients with ischemic heart disease suggest that IABP may reduce perioperative cardiac events in high-risk patients undergoing non-cardiac surgery.
This study presents the outcomes of five cases of IABP use in high-risk patients undergoing tracheal resection and discusses the role of IABP use in non-cardiac surgery.
CASE SUMMARIES

Case 1
A 64-year-old man was admitted with distress due to post-intubation tracheal stenosis after hospitalization for myocardial infarction (MI) 6 months prior to admission.
Echocardiography revealed an enlarged left ventricle (LV)
and ejection fraction (EF) of 20%.
The patient was determined to be a candidate for tracheal resection and anastomosis. Immediately after induction of anesthesia, the patient's blood pressure dropped and his condition deteriorated. It was decided to insert an IABP in order to stabilize the patient. The surgery was performed with no complications and the IABP device was removed 6 hours postoperatively. The patient was discharged with no complications.
Case 2
A 48-year-old man was referred to the center for postintubation tracheal stenosis after myocardial infarction 3. 
Case 5
A 62 year-old man was referred to the center for tracheal resection and anastomosis due to tracheal stenosis after a 35-day intubation period following MI and cardiopulmonary arrest 3 months prior to admission. Currently, the IABP is mainly used preoperatively or operatively in high-risk patients undergoing emergent cardiac surgery for multi-vessel coronary artery disease, recent MI, severe angina, and congestive heart failure (1, 8, 10).
General anesthesia and major surgeries are associated with higher mortality rates in patients suffering from advanced coronary disease, ischemic heart disease, left ventricular failure and irritability (11) (12) (13) . Operative and preoperative IABP use in such patients may improve postoperative prognosis and survival, reduce cardiac complications (12) (13) (14) , and reduce the length of hospital stay. Additionally, the device has been shown to be safe and cost-effective (15) .
There 
